“…Nonetheless, evidence available to date mainly consists of case-based reports [3][4][5]7], complemented by a small number of placebo-controlled trials [1,2,6] and is thus still considered rudimentary and largely inadequate to draw decisive conclusions regarding its therapeutic efficacy. It is widely acknowledged, however, that TMS has a highly valuable clinical application to stroke, and potentially, to other brain injured populations with acquired language disorders and even motor speech disorders.…”